en

PRODUCT DETAIL

Ryzneuta 20 mg injekčný roztok

Code 5923E
MA number EU/1/24/1793/001
Product Form: sol inj 1x1 ml/20 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 Immunomodulators/-stimulants
L03A Immunostimulants
L03AA Colony stimulating factors
L03AA18 Efbemalenograstim alfa
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 21.03.2024
Validity: 21.03.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 10.04.2024
eu-flag.png sk-flag.png